Eric Sievers - 11 Mar 2025 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Medical Officer
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Eric Sievers
Issuer symbol
BCAB
Transactions as of
11 Mar 2025
Transactions value $
$0
Form type
4
Filing time
13 Mar 2025, 16:11:25 UTC
Previous filing
24 Feb 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Award $0 +175,000 +90% $0 370,032 11 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 11, 2026, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February so long as the reporting person remains a service provider.